Voyager Biomedical
PrivateLast Round
Series A
Apr 4, 2025
Total Funding Raised
$5.82M
Company Overview
Voyager Biomedical operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Series A round in April 2025.
Voyager Biomedical is a medical device company that develops novel vascular access solutions, including the VenaSure cannulation device, to improve the lives of dialysis patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Voyager Biomedical Comparables
Compare Voyager Biomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aperture Biomedical | 85% | |
| VenoStent | 85% | |
| Xeltis | 77% |
For institutional investors. Book with your work email.
Voyager Biomedical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 4, 2025 | ||||
| Accelerator | Sep 27, 2017 | ||||
| Accelerator | Aug 10, 2016 | ||||
| Grant | May 20, 2016 |
For institutional investors. Book with your work email.
Voyager Biomedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Accelerator, Series A |
| NIH RADx | Series A |
| Texas Medical Center | Accelerator, Series A |
| Houston Angel Network | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2026
Monthly visitors increased 265% MoM.
- May 18, 2026
Monthly visitors increased 1118% MoM, reaching 268.
For institutional investors. Book with your work email.
Voyager Biomedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Voyager Biomedical's valuation, stock price, and market status.
Is Voyager Biomedical a public or private company?
Voyager Biomedical is a private company.
What is the current stock price of Voyager Biomedical?
Voyager Biomedical is a private company, so its shares have no public market price. Caplight tracks Voyager Biomedical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Voyager Biomedical worth (valuation)?
Valuation information for Voyager Biomedical is not publicly available.
Can I buy Voyager Biomedical stock?
Voyager Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Voyager Biomedical's last funding round?
Voyager Biomedical's most recent funding round was Series A on April 4, 2025.
Who are the main investors in Voyager Biomedical?
Key investors in Voyager Biomedical include MedTech Innovator, NIH RADx, Texas Medical Center, Houston Angel Network.
Will Voyager Biomedical IPO soon?
No public IPO plans have been announced for Voyager Biomedical.
How can I track Voyager Biomedical secondary market activity?
Caplight tracks bids, offers, and trades in Voyager Biomedical's shares on secondary markets.